139 related articles for article (PubMed ID: 9755864)
1. The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking.
Ferrer-Montiel AV; Gutiérrez LM; Apland JP; Canaves JM; Gil A; Viniegra S; Biser JA; Adler M; Montal M
FEBS Lett; 1998 Sep; 435(1):84-8. PubMed ID: 9755864
[TBL] [Abstract][Full Text] [Related]
2. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells.
Gutierrez LM; Viniegra S; Rueda J; Ferrer-Montiel AV; Canaves JM; Montal M
J Biol Chem; 1997 Jan; 272(5):2634-9. PubMed ID: 9006897
[TBL] [Abstract][Full Text] [Related]
3. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
4. Peptides that mimic the carboxy-terminal domain of SNAP-25 block acetylcholine release at an Aplysia synapse.
Apland JP; Biser JA; Adler M; Ferrer-Montiel AV; Montal M; Canaves JM; Filbert MG
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S23-6. PubMed ID: 10594895
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin E-insensitive mutants of SNAP-25 fail to bind VAMP but support exocytosis.
Washbourne P; Bortoletto N; Graham ME; Wilson MC; Burgoyne RD; Montecucco C
J Neurochem; 1999 Dec; 73(6):2424-33. PubMed ID: 10582602
[TBL] [Abstract][Full Text] [Related]
8. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
Lawrence GW; Foran P; Dolly JO
Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
11. Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers.
Höhne-Zell B; Gratzl M
FEBS Lett; 1996 Sep; 394(2):109-16. PubMed ID: 8843145
[TBL] [Abstract][Full Text] [Related]
12. SNAP-25 is required for a late postdocking step in Ca2+-dependent exocytosis.
Banerjee A; Kowalchyk JA; DasGupta BR; Martin TF
J Biol Chem; 1996 Aug; 271(34):20227-30. PubMed ID: 8702751
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
14. Small peptides patterned after the N-terminus domain of SNAP25 inhibit SNARE complex assembly and regulated exocytosis.
Blanes-Mira C; Merino JM; Valera E; Fernández-Ballester G; Gutiérrez LM; Viniegra S; Pérez-Payá E; Ferrer-Montiel A
J Neurochem; 2004 Jan; 88(1):124-35. PubMed ID: 14675156
[TBL] [Abstract][Full Text] [Related]
15. The t-SNAREs syntaxin 1 and SNAP-25 are present on organelles that participate in synaptic vesicle recycling.
Walch-Solimena C; Blasi J; Edelmann L; Chapman ER; von Mollard GF; Jahn R
J Cell Biol; 1995 Feb; 128(4):637-45. PubMed ID: 7860636
[TBL] [Abstract][Full Text] [Related]
16. Differential contribution of syntaxin 1 and SNAP-25 to secretion in noradrenergic and adrenergic chromaffin cells.
Baltazar G; Tomé A; Carvalho AP; Duarte EP
Eur J Cell Biol; 2000 Dec; 79(12):883-91. PubMed ID: 11152280
[TBL] [Abstract][Full Text] [Related]
17. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca(2+)-dependent exocytosis in chromaffin cells.
Gutiérrez LM; Cànaves JM; Ferrer-Montiel AV; Reig JA; Montal M; Viniegra S
FEBS Lett; 1995 Sep; 372(1):39-43. PubMed ID: 7556639
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool.
Stigliani S; Raiteri L; Fassio A; Bonanno G
J Neurochem; 2003 Apr; 85(2):409-21. PubMed ID: 12675917
[TBL] [Abstract][Full Text] [Related]
19. Characterization of SNARE protein expression in beta cell lines and pancreatic islets.
Wheeler MB; Sheu L; Ghai M; Bouquillon A; Grondin G; Weller U; Beaudoin AR; Bennett MK; Trimble WS; Gaisano HY
Endocrinology; 1996 Apr; 137(4):1340-8. PubMed ID: 8625909
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
